| 000 | 01012 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513084252.0 | ||
| 264 | 0 | _c19960227 | |
| 008 | 199602s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.311.7020.1641a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCleare, A J | |
| 245 | 0 | 0 |
_aDeciding which selective serotonin reuptake inhibitor to prescribe. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cDec 1995 |
||
| 300 |
_a1641 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xadverse effects |
| 650 | 0 | 4 |
_aDepression _xdrug therapy |
| 650 | 0 | 4 |
_aFluoxetine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPractice Patterns, Physicians' |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 311 _gno. 7020 _gp. 1641 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.311.7020.1641a _zAvailable from publisher's website |
| 999 |
_c8554900 _d8554900 |
||